Common dietary supplement shown to lower risk of Type 2 diabetes

Washington: A new research has demonstrated that an over-the-counter dietary supplement may help slow down the development of insulin resistance and glucose intolerance, that are the markers of Type 2 diabetes and metabolic syndrome.

According to the ULCA (University of California, Los Angeles) researchers, a naturally produced amino acid-like molecule called GABA was given orally to obese and insulin resistant mice, who were in the early stages of Type 2 diabetes.

In the early pre-clinical study, researchers found that the GABA suppressed the inflammatory immune responses that are involved in the development of this condition.

GABA also helped in preventing the progression of the disease, improved glucose tolerance and insulin sensitivity, even after the onset of Type 2 diabetes in mice.


By continuing to use the site, you agree to the use of cookies. You can find out more by clicking this link